These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12667655)

  • 1. Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor.
    Loscher CE; Mills KH; Lynch MA
    J Neuroimmunol; 2003 Apr; 137(1-2):117-24. PubMed ID: 12667655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual role for interleukin-1 in LTP in mouse hippocampal slices.
    Ross FM; Allan SM; Rothwell NJ; Verkhratsky A
    J Neuroimmunol; 2003 Nov; 144(1-2):61-7. PubMed ID: 14597099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
    Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
    J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.
    Touzani O; Boutin H; LeFeuvre R; Parker L; Miller A; Luheshi G; Rothwell N
    J Neurosci; 2002 Jan; 22(1):38-43. PubMed ID: 11756486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epistatic interrelationships of IL-1, IL-1 receptor antagonist, and the type I IL-1 receptor.
    Irikura VM; Lagraoui M; Hirsh D
    J Immunol; 2002 Jul; 169(1):393-8. PubMed ID: 12077269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
    Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
    Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10--a role for IL-1 beta?
    Lynch AM; Walsh C; Delaney A; Nolan Y; Campbell VA; Lynch MA
    J Neurochem; 2004 Feb; 88(3):635-46. PubMed ID: 14720213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
    Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
    Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 receptor antagonism.
    Nikolic-Paterson DJ; Lan HY; Atkins RC
    Semin Nephrol; 1996 Nov; 16(6):583-90. PubMed ID: 9125803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of IL-1 receptor antagonist on the level of cytokine in the rat corneal grafts and aqueous humor after corneal transplantation].
    Zhang WH; Zhai CB; Pan ZQ; Wu YY
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):587-91. PubMed ID: 14766071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ovarian action of interleukin-1 is receptor mediated: reversal by a naturally occurring interleukin-1 receptor antagonist.
    Kokia E; Ben-Shlomo I; Adashi EY
    Fertil Steril; 1995 Jan; 63(1):176-81. PubMed ID: 7805908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.
    Somm E; Cettour-Rose P; Asensio C; Charollais A; Klein M; Theander-Carrillo C; Juge-Aubry CE; Dayer JM; Nicklin MJ; Meda P; Rohner-Jeanrenaud F; Meier CA
    Diabetologia; 2006 Feb; 49(2):387-93. PubMed ID: 16385385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.
    Ruggiero P; Bossù P; Macchia G; Del Grosso E; Sabbatini V; Bertini R; Colagrande A; Bizzarri C; Maurizi G; Di Cioccio V; D'Andrea G; Di Giulio A; Frigerio F; Grifantini R; Grandi G; Tagliabue A; Boraschi D
    J Immunol; 1997 Apr; 158(8):3881-7. PubMed ID: 9103457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of brain interleukin-1 beta (IL-1 beta) system mRNAs in response to pathophysiological concentrations of IL-1 beta in the cerebrospinal fluid.
    Ilyin SE; Sonti G; Gayle D; Plata-Salamán CR
    J Mol Neurosci; 1996; 7(3):169-81. PubMed ID: 8906613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interleukin-1 receptor antagonist and its delivery by gene transfer.
    Evans CH; Robbins PD
    Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors.
    Simoncsits A; Bristulf J; Tjörnhammar ML; Cserzö M; Pongor S; Rybakina E; Gatti S; Bartfai T
    Cytokine; 1994 Mar; 6(2):206-14. PubMed ID: 8032002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effects of the lichen glucan PB-2, extracted from Flavoparmelia baltimorensis, on the induction of long-term potentiation in the dentate gyrus of the anesthetized rat: possible mediation via adrenaline beta- and interleukin-1 receptors.
    Edagawa Y; Sato F; Saito H; Takeda T; Shimizu N; Narui T; Shibata S; Ito Y
    Brain Res; 2005 Jan; 1032(1-2):183-92. PubMed ID: 15680958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.